天津发展(00882):力生制药前三季度归母净利润3.71亿元 同比增加119.05%

智通财经
Oct 24, 2025

智通财经APP讯,天津发展(00882)发布公告,公司间接非全资附属天津力生制药股份有限公司(力生制药)截至2025年9月30日止9个月取得营业总收入10.07亿元,同比减少1.61%;归属于母公司所有者的净利润3.71亿元,同比增加119.05%;基本每股收益1.44元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10